BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1747611)

  • 1. Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes.
    Laakso M; Kesäniemi A; Kervinen K; Jauhiainen M; Pyörälä K
    BMJ; 1991 Nov; 303(6811):1159-62. PubMed ID: 1747611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
    Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
    Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein e4 allele is predictor of coronary artery disease death in elderly patients with type 2 diabetes mellitus.
    Guang-da X; You-ying L; Zhi-song C; Yu-sheng H; Xiang-jiu Y
    Atherosclerosis; 2004 Jul; 175(1):77-81. PubMed ID: 15186949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects.
    Vauhkonen I; Niskanen L; Ryynänen M; Voutilainen R; Partanen J; Töyry J; Mercuri M; Rauramaa R; Uusitupa M
    Diabet Med; 1997 Sep; 14(9):748-56. PubMed ID: 9300224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study.
    Kuusisto J; Koivisto K; Mykkänen L; Helkala EL; Vanhanen M; Hänninen T; Kervinen K; Kesäniemi YA; Riekkinen PJ; Laakso M
    BMJ; 1997 Oct; 315(7115):1045-9. PubMed ID: 9366728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E polymorphism in diabetic and non-diabetic patients: does it really contribute to atherosclerosis?
    Camsari A; Tamer L; Aras Ateş N; Pekdemir H; Ciçek D; Ercan B; Camdeviren H; Atik U
    Acta Cardiol; 2005 Aug; 60(4):409-14. PubMed ID: 16128374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein e4 allele and endothelium-dependent arterial dilation in Type 2 diabetes mellitus without angiopathy.
    Guangda X; Yuhua W
    Diabetologia; 2003 Apr; 46(4):514-9. PubMed ID: 12739024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus.
    Ukkola O; Kervinen K; Salmela PI; von Dickhoff K; Laakso M; Kesäniemi YA
    Atherosclerosis; 1993 Jun; 101(1):9-15. PubMed ID: 8216506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study.
    Humphries SE; Talmud PJ; Hawe E; Bolla M; Day IN; Miller GJ
    Lancet; 2001 Jul; 358(9276):115-9. PubMed ID: 11463413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
    Duman BS; Oztürk M; Yilmazer S; Hatemi H
    Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose.
    Erkkilä AT; Sarkkinen ES; Lindi V; Lehto S; Laakso M; Uusitupa MI
    Am J Clin Nutr; 2001 Apr; 73(4):746-52. PubMed ID: 11273849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E phenotypes in patients with coronary artery disease.
    Miida T
    Tohoku J Exp Med; 1990 Mar; 160(3):177-87. PubMed ID: 2353352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform patterns of apolipoprotein E in diabetes mellitus.
    Black SC; Hewett S; Kotubi Y; Brunt RV; Reckless JP
    Diabet Med; 1990 Jul; 7(6):532-9. PubMed ID: 2142057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between severity of coronary artery disease and apolipoprotein E gene polymorphism.
    Arslan Ince FD; Atay A; Köseoğlu M; Yeşil M; Deveci E
    Anadolu Kardiyol Derg; 2010 Jun; 10(3):202-8. PubMed ID: 20538553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of the apolipoprotein E gene polymorphism in Turkish Type 2 Diabetic Patients with and without diabetic foot ulcers.
    Mehmet E; Zuhal E; Mustafa K; Soner S; Aslı T; Sevki C
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S30-3. PubMed ID: 26476487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial.
    Orchard TJ; Eichner J; Kuller LH; Becker DJ; McCallum LM; Grandits GA
    Ann Epidemiol; 1994 Jan; 4(1):40-5. PubMed ID: 8205270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between apolipoprotein E-polymorphism and Ischemic heart disease patients with or without type 2 diabetes mellitus: a preliminary study in Kuwait.
    Al-Majed HT; Qasem JA; Al-Sherifi AK; Al-Attar AA; Qasem AA; Abdullah SA
    Arch Iran Med; 2011 Nov; 14(6):385-8. PubMed ID: 22039842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apo E 2 phenotypes in type II diabetics with and without insulin therapy.
    Vogelberg KH; Maucy E
    Klin Wochenschr; 1988 Aug; 66(15):690-3. PubMed ID: 3050266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease.
    Tziakas DN; Chalikias GK; Antonoglou CO; Veletza S; Tentes IK; Kortsaris AX; Hatseras DI; Kaski JC
    J Am Coll Cardiol; 2006 Dec; 48(12):2471-81. PubMed ID: 17174184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.